![Nir Naor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nir Naor
Finanzdirektor/CFO bei
NEURONETICS, INC.
Vermögen: 1 Mio $ am 31.08.2026
Profil
Nir Naor is currently an Independent Director at Brainstorm Cell Therapeutics, Inc. since 2023.
Mr. Naor is also CFO, Secretary, Treasurer & Executive VP at Neuronetics, Inc. starting in 2026.
Former positions include Auditor at KPMG Corporate Finance LLC from 2001 to 2005; Chief Financial Officer-United States at UCB SA from 2012 to 2017; Chief Financial Officer-US Americas at Molnlycke Health Care US LLC from 2017 to 2021; Chief Financial Officer at Arbor Pharmaceuticals, Inc. in 2021; Chief Financial Officer at HMNC Holding GmbH from 2021 to 2022; Chief Financial Officer at QuVa Pharma, Inc. in 2023; and Chief Financial Officer at Axogen, Inc. from 2023 to 2025.
Education includes undergraduate, graduate, and MBA degrees from Tel-Aviv University; a graduate degree from the University of Hamburg; and an MBA from the International Institute for Management Development.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEURONETICS, INC. 0.76% | 23.07.2026 | 500’000 ( 0.76% ) | 1 Mio $ | 31.08.2026 |
| 26.02.2026 | 31’465 ( 0.29% ) | 33 510 $ | 31.08.2026 |
Aktive Positionen von Nir Naor
| Unternehmen | Position | Beginn |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 20.06.2023 |
| NEURONETICS, INC. | Finanzdirektor/CFO | 23.07.2026 |
Ehemalige bekannte Positionen von Nir Naor
| Unternehmen | Position | Ende |
|---|---|---|
| AXOGEN, INC. | Finanzdirektor/CFO | 11.05.2025 |
QuVa Pharma, Inc.
 QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Finanzdirektor/CFO | 01.09.2023 |
HMNC Holding GmbH
 HMNC Holding GmbH Financial ConglomeratesFinance Provides investment services | Finanzdirektor/CFO | 01.10.2022 |
Arbor Pharmaceuticals, Inc.
 Arbor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on neuroscience, cardiovascular and pediatric markets | Finanzdirektor/CFO | 01.09.2021 |
Molnlycke Health Care US LLC
 Molnlycke Health Care US LLC Medical SpecialtiesHealth Technology Manufactures surgical and wound care products | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Nir Naor
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
KPMG Corporate Finance LLC
 KPMG Corporate Finance LLC Investment ManagersFinance Provides investment advice | Finance |
Neuronetics, Inc.
 Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hamburg
 University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molnlycke Health Care US LLC
Molnlycke Health Care US LLC Medical SpecialtiesHealth Technology Manufactures surgical and wound care products | Health Technology |
Axogen, Inc.
 Axogen, Inc. Medical SpecialtiesHealth Technology Provides products and technologies for peripheral nerve reconstruction and regeneration | Health Technology |
QuVa Pharma, Inc.
QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Health Technology |
Arbor Pharmaceuticals, Inc.
Arbor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on neuroscience, cardiovascular and pediatric markets | Health Technology |
HMNC Holding GmbH
HMNC Holding GmbH Financial ConglomeratesFinance Provides investment services | Finance |
